Form 4 Tracker
Merck & Co., Inc.
MRK

76 insider filings · Latest: Sep 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 13, 2026Aug 13 9:02 PMChirfi GuindoEVP, Access, Policy & Comms
Sale
10,000$135.00$1.4M36,613.127(D)

View →

Aug 13, 2026Aug 13 8:15 PMCHIRFI GUINDO
Proposed Sale
10,000$135.00$1.4M—

View →

Aug 12, 2026Aug 13 8:11 PMJennifer ZacharyEVP, General Counsel
Sale
80,315$133.46$10.7M45,509.254(D)

View →

Aug 12, 2026Aug 12 8:23 PMRICHARD ROBERT DELUCA JR
Proposed Sale
11,699$131.63$1.5M—

View →

Aug 12, 2026Aug 12 8:19 PMJENNIFER L ZACHARY
Proposed Sale
80,315$133.46$10.7M—

View →

Aug 12, 2026Aug 12 8:10 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
11,699$131.63$1.5M110,167.07(D)

View →

Aug 11, 2026Aug 12 8:10 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
12,837$131.76$1.7M121,866.07(D)

View →

Aug 10, 2026Aug 12 8:10 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
20,784$130.43$2.7M134,703.07(D)

View →

Aug 11, 2026Aug 11 8:14 PMRICHARD ROBERT DELUCA JR
Proposed Sale
12,837$131.76$1.7M—

View →

Aug 10, 2026Aug 10 8:43 PMRICHARD ROBERT DELUCA JR
Proposed Sale
20,784$130.43$2.7M—

View →

Aug 6, 2026Aug 10 8:28 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
6,050$130.38$788.8K155,487.07(D)

View →

Aug 5, 2026Aug 7 8:21 PMDavid R. MaraldoEVP & Pres. MMD
Sale
18,706$128.72$2.4M18,212.434(D)

View →

Aug 5, 2026Aug 7 8:19 PMDavid Michael WilliamsEVP,Chief Info&Digital Officer
Sale
52,847$128.77$6.8M31,716.037(D)

View →

Aug 6, 2026Aug 7 8:17 PMChirfi GuindoEVP, Access, Policy & Comms
Sale
15,000$131.00$2.0M46,613.127(D)

View →

Aug 6, 2026Aug 6 8:47 PMCHIRFI GUINDO
Proposed Sale
15,000$131.00$2.0M—

View →

Aug 6, 2026Aug 6 8:45 PMRICHARD ROBERT DELUCA JR
Proposed Sale
6,050$130.38$788.8K—

View →

Aug 5, 2026Aug 5 8:27 PMDAVID M WILLIAMS
Proposed Sale
52,847$128.77$6.8M—

View →

Aug 5, 2026Aug 5 8:26 PMDAVID MARALDO
Proposed Sale
18,706$128.72$2.4M—

View →

Feb 9, 2026Feb 13 9:15 PMCHIRFI GUINDO
Proposed Sale
20,000$118.41$2.4M—

View →

Feb 12, 2026Feb 12 9:02 PMChirfi GuindoChief Marketing Officer
Sale
10,000$121.46$1.2M60,615.127(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 29, 2026Jun 2 5:57 PMDouglas M Baker JRDirector
Grant/Award
1,853.1—11,518.208(D)

View →

May 5, 2026May 7 4:18 PMJennifer ZacharyEVP, General Counsel
Grant/Award
47,376$113.1535,312(D)

View →

May 5, 2026May 7 4:14 PMDavid Michael WilliamsEVP,Chief Info&Digital Officer
Grant/Award
18,222$113.1513,582(D)

View →

May 5, 2026May 7 4:10 PMCaroline LitchfieldEVP & CFO
Grant/Award
62,474$113.1546,566(D)

View →

May 5, 2026May 7 4:07 PMDean Y LiExecutive VP & President, MRL
Grant/Award
78,092$113.1558,207(D)

View →

May 5, 2026May 7 4:03 PMBetty D LarsonEVP, Chief HR Officer
Grant/Award
31,237$113.1523,283(D)

View →

May 5, 2026May 7 3:56 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Grant/Award
46,855$113.1534,924(D)

View →

May 5, 2026May 7 3:52 PMRobert M DavisDirector, Chairman, CEO & President
Grant/Award
187,421$113.15139,697(D)

View →

May 5, 2026May 7 3:48 PMBrian FoardEVP, Specialty, Pharma, & ID
Grant/Award
77,000$113.1531,044(D)

View →

May 5, 2026May 7 3:45 PMDavid R. MaraldoEVP & Pres. MMD
Grant/Award
29,155$113.1521,731(D)

View →

May 5, 2026May 7 3:42 PMJohannes Jacobus OosthuizenEVP, Oncology & Int?l
Grant/Award
41,649$113.1531,044(D)

View →

May 5, 2026May 7 3:39 PMDalton E. Smart IIISVP Fin. - Global Controller
Grant/Award
7,343$113.155,045(D)

View →

May 5, 2026May 7 3:36 PMChirfi GuindoEVP, Access, Policy & Comms
Grant/Award
26,030$113.1519,402(D)

View →

May 2, 2026May 5 5:51 PMDalton E. Smart IIISVP Fin. - Global Controller
Option Exercise
383—0(D)

View →

May 2, 2026May 5 5:47 PMDavid R. MaraldoEVP & Pres. MMD
Option Exercise
552—0(D)

View →

Apr 29, 2026May 1 10:54 PMChirfi GuindoEVP, Access, Policy & Comms
Option Exercise
1,967—3,935(D)

View →

Apr 29, 2026May 1 10:32 PMSanat ChattopadhyayExe V-P & Pres. MMD
Option Exercise
2,597—5,194(D)

View →

Apr 29, 2026May 1 10:20 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Option Exercise
2,518—5,037(D)

View →

Apr 29, 2026May 1 9:56 PMDavid Michael WilliamsEVP,Chief Info&Digital Officer
Option Exercise
1,377—2,755(D)

View →

Apr 30, 2026May 1 9:55 PMDalton E. Smart IIISVP Fin. - Global Controller
Option Exercise
464—465(D)

View →